| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 87,282.48× | 87,282.48× | 2,151.57× | 208.86× | 74.25× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 92.26× | 92.26× | 100.13× | 78.95× | 84.04× | ||
| 7,93,901.71× | 7,93,901.71× | 19,674.07× | 2,050.68× | 978.89× | ||
| −7,06,526.97× | −7,06,526.97× | −17,422.37× | −1,762.87× | −820.60× | ||
| 1.62× | 1.57× | 1.57× | 2.45× | 3.28× | ||
| 1.04× | 1.04× | 1.01× | 1.48× | 1.58× | ||
| −4.61× | −4.61× | 4.38× | 6.31× | −1.50× | ||
| −2.52× | −2.52× | 2.91× | 3.62× | −0.86× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Inventory Days (DIO) | 74.25 | 208.86 | 2,151.57 | 87,282.48 | 87,282.48 | |
| Receivable Days (DSO) | 84.04 | 78.95 | 100.13 | 92.26 | 92.26 | |
| Payable Days (DPO) | 978.89 | 2,050.68 | 19,674.07 | 7,93,901.71 | 7,93,901.71 | |
| Cash Conversion Cycle (days) | -820.60 | -1,762.87 | -17,422.37 | -7,06,526.97 | -7,06,526.97 | |
| Working Capital Turnover | 3.28 | 2.45 | 1.57 | 1.57 | 1.62 | |
| Asset Turnover | 1.58 | 1.48 | 1.01 | 1.04 | 1.04 | |
| Cash Conversion (CFO/Net Income) | -1.50 | 6.31 | 4.38 | -4.61 | -4.61 | |
| CFO/EBITDA | -0.86 | 3.62 | 2.91 | -2.52 | -2.52 |